Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 511

1.

Inducible costimulator (ICOS) is a marker for highly suppressive antigen-specific T cells sharing features of TH17/TH1 and regulatory T cells.

Vocanson M, Rozieres A, Hennino A, Poyet G, Gaillard V, Renaudineau S, Achachi A, Benetiere J, Kaiserlian D, Dubois B, Nicolas JF.

J Allergy Clin Immunol. 2010 Aug;126(2):280-9, 289.e1-7. doi: 10.1016/j.jaci.2010.05.022. Epub 2010 Jul 10.

PMID:
20624644
[PubMed - indexed for MEDLINE]
2.

Natural killer cells prevent CD28-mediated Foxp3 transcription in CD4+CD25- T lymphocytes.

Brillard E, Pallandre JR, Chalmers D, Ryffel B, Radlovic A, Seilles E, Rohrlich PS, Pivot X, Tiberghien P, Saas P, Borg C.

Exp Hematol. 2007 Mar;35(3):416-25.

PMID:
17309822
[PubMed - indexed for MEDLINE]
3.

Downregulation of CD4+CD25+ regulatory T cells may underlie enhanced Th1 immunity caused by immunization with activated autologous T cells.

Cao Q, Wang L, Du F, Sheng H, Zhang Y, Wu J, Shen B, Shen T, Zhang J, Li D, Li N.

Cell Res. 2007 Jul;17(7):627-37.

PMID:
17563757
[PubMed - indexed for MEDLINE]
Free Article
4.

Regulatory function of CD4+CD25+ T cells from Class II MHC-deficient mice in contact hypersensitivity responses.

Kish DD, Gorbachev AV, Fairchild RL.

J Leukoc Biol. 2007 Jul;82(1):85-92. Epub 2007 Apr 5.

PMID:
17412917
[PubMed - indexed for MEDLINE]
Free Article
5.

Role of STAT3 in CD4+CD25+FOXP3+ regulatory lymphocyte generation: implications in graft-versus-host disease and antitumor immunity.

Pallandre JR, Brillard E, Créhange G, Radlovic A, Remy-Martin JP, Saas P, Rohrlich PS, Pivot X, Ling X, Tiberghien P, Borg C.

J Immunol. 2007 Dec 1;179(11):7593-604.

PMID:
18025205
[PubMed - indexed for MEDLINE]
Free Article
6.
7.

IL-2-independent generation of FOXP3(+)CD4(+)CD8(+)CD25(+) cytotoxic regulatory T cell lines from human umbilical cord blood.

Nakamura S, Suzuki M, Sugimoto A, Tsuji-Takayama K, Yamamoto M, Otani T, Inoue T, Harashima A, Okochi A, Motoda R, Yamasaki F, Orita K, Kibata M.

Exp Hematol. 2007 Feb;35(2):287-96.

PMID:
17258077
[PubMed - indexed for MEDLINE]
8.

Expression of ICOS on human melanoma-infiltrating CD4+CD25highFoxp3+ T regulatory cells: implications and impact on tumor-mediated immune suppression.

Strauss L, Bergmann C, Szczepanski MJ, Lang S, Kirkwood JM, Whiteside TL.

J Immunol. 2008 Mar 1;180(5):2967-80.

PMID:
18292519
[PubMed - indexed for MEDLINE]
Free Article
9.

Human CD25+ regulatory T cells maintain immune tolerance to nickel in healthy, nonallergic individuals.

Cavani A, Nasorri F, Ottaviani C, Sebastiani S, De Pità O, Girolomoni G.

J Immunol. 2003 Dec 1;171(11):5760-8.

PMID:
14634084
[PubMed - indexed for MEDLINE]
Free Article
10.

G protein-coupled receptor 83 overexpression in naive CD4+CD25- T cells leads to the induction of Foxp3+ regulatory T cells in vivo.

Hansen W, Loser K, Westendorf AM, Bruder D, Pfoertner S, Siewert C, Huehn J, Beissert S, Buer J.

J Immunol. 2006 Jul 1;177(1):209-15.

PMID:
16785516
[PubMed - indexed for MEDLINE]
Free Article
11.

Ex vivo expansion of CD4+CD25+FoxP3+ T regulatory cells based on synergy between IL-2 and 4-1BB signaling.

Elpek KG, Yolcu ES, Franke DD, Lacelle C, Schabowsky RH, Shirwan H.

J Immunol. 2007 Dec 1;179(11):7295-304.

PMID:
18025172
[PubMed - indexed for MEDLINE]
Free Article
12.

Unique phenotype of human tonsillar and in vitro-induced FOXP3+CD8+ T cells.

Siegmund K, Rückert B, Ouaked N, Bürgler S, Speiser A, Akdis CA, Schmidt-Weber CB.

J Immunol. 2009 Feb 15;182(4):2124-30. doi: 10.4049/jimmunol.0802271.

PMID:
19201865
[PubMed - indexed for MEDLINE]
Free Article
13.

TLR2 agonists enhance CD8+Foxp3+ regulatory T cells and suppress Th2 immune responses during allergen immunotherapy.

Tsai YG, Yang KD, Niu DM, Chien JW, Lin CY.

J Immunol. 2010 Jun 15;184(12):7229-37. doi: 10.4049/jimmunol.1000083. Epub 2010 May 7.

PMID:
20483759
[PubMed - indexed for MEDLINE]
Free Article
14.

Delayed functional maturation of natural regulatory T cells in the medulla of postnatal thymus: role of TSLP.

Jiang Q, Su H, Knudsen G, Helms W, Su L.

BMC Immunol. 2006 Apr 3;7:6.

PMID:
16579866
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Preferential development of CD4 and CD8 T regulatory cells in RasGRP1-deficient mice.

Chen X, Priatel JJ, Chow MT, Teh HS.

J Immunol. 2008 May 1;180(9):5973-82.

PMID:
18424717
[PubMed - indexed for MEDLINE]
Free Article
16.

CD8+ Foxp3+ regulatory T cells mediate immunosuppression in prostate cancer.

Kiniwa Y, Miyahara Y, Wang HY, Peng W, Peng G, Wheeler TM, Thompson TC, Old LJ, Wang RF.

Clin Cancer Res. 2007 Dec 1;13(23):6947-58.

PMID:
18056169
[PubMed - indexed for MEDLINE]
Free Article
17.

CD8+ Foxp3+ T cells share developmental and phenotypic features with classical CD4+ Foxp3+ regulatory T cells but lack potent suppressive activity.

Mayer CT, Floess S, Baru AM, Lahl K, Huehn J, Sparwasser T.

Eur J Immunol. 2011 Mar;41(3):716-25. doi: 10.1002/eji.201040913. Epub 2011 Feb 11.

PMID:
21312192
[PubMed - indexed for MEDLINE]
18.

CD44 expression positively correlates with Foxp3 expression and suppressive function of CD4+ Treg cells.

Liu T, Soong L, Liu G, König R, Chopra AK.

Biol Direct. 2009 Oct 23;4:40. doi: 10.1186/1745-6150-4-40.

PMID:
19852824
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Antagonistic nature of T helper 1/2 developmental programs in opposing peripheral induction of Foxp3+ regulatory T cells.

Wei J, Duramad O, Perng OA, Reiner SL, Liu YJ, Qin FX.

Proc Natl Acad Sci U S A. 2007 Nov 13;104(46):18169-74. Epub 2007 Oct 31.

PMID:
17978190
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Both regulatory T cells and antitumor effector T cells are primed in the same draining lymph nodes during tumor progression.

Hiura T, Kagamu H, Miura S, Ishida A, Tanaka H, Tanaka J, Gejyo F, Yoshizawa H.

J Immunol. 2005 Oct 15;175(8):5058-66.

PMID:
16210609
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk